Padcev, a drug Pfizer acquired in 2023, is a part of the only chemo-free treatment for bladder cancer patients newly ...

Maintaining dividend aristocrat status isn’t easy, as it requires companies to pay out dividends consistently (and raise them ...

Investors looking for a way to pump up their passive income streams want to turn their attention toward the pharmaceutical ...

We recently published a list of 8 Most Undervalued Pot Stocks to Buy According to Analysts. In this article, we are going to ...

Pfizer's high initial dividend yield, solid ratings, and promising pipeline make it a potentially undervalued investment. See ...

I have selected Pfizer and Verizon as my top two high dividend yield companies to invest in for November 2024. Click here to ...

Dividend stocks provide investors with reliable passive income. These four health care picks look like outstanding ideas now.

Political uncertainty has created buying opportunities among blue-chip healthcare stocks with big-time dividends.

Dividend stocks have long been favored by investors for the income they generate, and they become even more appealing when ...

Now and then, though, I stumble across high-yielding dividend stocks that aren’t yield traps. I believe that one such example is Pfizer (PFE). Interestingly, Pfizer’s 5.9% dividend yield is ...

Moderna is a good investment for the vaccine market, while Pfizer is a diversified firm trading at a discount. PFE stock is a ...

Not always. Some companies with exceptionally high dividend yields can easily afford to keep the dividends flowing. Pfizer (NYSE: PFE) is in that group, in my opinion. The big drugmaker's forward ...